Efficacy of OKT3 as primary therapy for histologically confirmed acute renal allograft rejection

Transplantation

Volumn 64, Issue 10, 1997, Pages 1428-1432

  Kamath, Suresh ^a   Dean, Dorothy ^a   Peddi, V Ram ^a,b   Schroeder, Timothy J ^a   Alexander, J Wesley ^a   Cavallo, Tito ^a   First, M Roy ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; METHYLPREDNISOLONE; OKT 3; PREDNISONE;

ADULT; AGED; ARTICLE; DRUG EFFICACY; FEMALE; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; PANCREAS TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

EID: 0030782172     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199711270-00009     Document Type: Article

References (13)

1. Cosimi AB, Burton RC, Colvin RB, et al. Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation 1981; 32: 535.
2. Ortho Multicenter Transplant Study Group. A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. N Engl J Med 1985; 313: 337.
3. Norman DJ, Barry JM, Funnell B, Hennell K, Goldstein G. OKT3 for the treatment of acute steroid and ATG resistant rejection in renal allograft transplantation. Transplant Proc 1985; 17: 2744.
4. Flye W, Kashgarian M, Gaudio K, et al. Cyclosporine and OKT3 salvage for steroid and ATG resistant renal transplant rejection. Transplant Proc 1985; 17: 2748.
5. Monaco A, Goldstein G, Barnes L. Use of Orthoclone OKT3 monoclonal antibody to reverse acute renal allograft rejection unresponsive to treatment with conventional immunosuppressive regimens. Transplant Proc 1987; 19: 28.
6. Thistlethwaite JR, Haag BW, Gaber AO, et al. OKT3 treatment of steroid resistant renal allograft rejection. Transplantation 1987; 43: 176.
7. Ponticelli C, Rivolta E, Tarantino A, De Vecchi A, Vegeto A. Rescue of severe steroid resistant rejection with OKT3. Transplant Proc 1987; 19: 1908.
8. Norman DJ, Barry JM, Bennett WM, et al. The use of OKT3 in cadaveric renal transplantation for rejection that is unresponsive to conventional antirejection therapy. Am J Kidney Dis 1988; 11: 90.
9. Strate M, Jorgensen KA, Rohr N, Birkland SA. Orthoclone OKT3 as first line therapy in acute renal allograft rejection. Transplant Proc 1990; 22: 219.
10. Tesi RJ, Elkhammas EA, Henry ML, Ferguson RM. OKT3 for primary therapy of the first rejection episode in kidney transplants. Transplantation 1993; 55: 1023.
11. Solez K, Axelson RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: S-30.
12. Hricik DE, Almawi WY, Strom TB. Trends in the use of glucocorticoids in renal transplantation. Transplantation 1994; 57: 979.
13. Schroeder TJ, First MR, Mansour ME, et al. Antimurine antibody formation following OKT3 therapy. Transplantation 1990; 49: 48.